4//SEC Filing
Betz Stephen F. 4
Accession 0000950170-24-101434
CIK 0001658247other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:31 PM ET
Size
4.7 KB
Accession
0000950170-24-101434
Insider Transaction Report
Form 4
Betz Stephen F.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-08-26$53.19/sh−3,000$159,570→ 69,611 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001886575
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 4:31 PM ET
- Size
- 4.7 KB